Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Galena Biopharma Inc    

 SummaryNewsCalendarCompanyFinancialsRevisions 
Financials ($)
Sales 2017 -
EBIT 2017 -20,0 M
Net income 2017 -
Debt 2017 -
Yield 2017 -
Sales 2018 -
EBIT 2018 -50,8 M
Net income 2018 -52,9 M
Debt 2018 -
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
Capi. / Sales2017 0
Capi. / Sales2018 0
Capitalization 14,2 M
More Financials
Company
Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs.The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to... 
Sector
Pharmaceuticals
Calendar

- No events available -

More about the company
Latest news on GALENA BIOPHARMA INC
09/25 GALENA BIOPHARMA, INC. (NASDAQ : GALE) Files An 8-K Notice of Delisting or Failu..
09/25 GALENA BIOPHARMA, INC. : Notice of Delisting or Failure to Satisfy a Continued L..
09/14 GALENA BIOPHARMA, INC. (NASDAQ : GALE) Files An 8-K Regulation FD Disclosure
09/14 GALENA BIOPHARMA, INC. : Regulation FD Disclosure, Other Events (form 8-K)
09/13 GALENA BIOPHARMA : and BioVascular, Inc. Reaffirm GALE 401 Partnership
09/11 GALENA BIOPHARMA, INC. : Entry into a Material Definitive Agreement (form 8-K)
09/11 Galena Biopharma and BioVascular, Inc. Reaffirm GALE-401 Partnership
09/09 GALENA BIOPHARMA : Biopharmaceutical firm pays $7.5M to settle kickback claims
09/09 GALENA BIOPHARMA INC : . to Pay More Than $7.55 Million to Resolve Alleged False..
09/08 GALENA BIOPHARMA INC : . to Pay More Than $7.55 Million to Resolve Alleged False..
More news
Sector news : Pharmaceuticals - NEC
09:36a SHANGHAI PHARMACEUTICALS : CVC, others explore sale of drugmaker Alvogen - Bloom..
09/25 European shares stay near highs as Merkel hangs on to power
09/25 Lufthansa names former CFO Kley as new chairman
09/25 ALLERGAN : boosts shares with $2 billion buyback
09/24 SAP to buy customer management software firm Gigya
More sector news : Pharmaceuticals - NEC
Latest Tweets
09/18Stock Performance Review on Biotech Industry — Galena Biopharma, Idera Pharma.. 
09/11$GALE: Galena Biopharma reaffirms partnership with BioVascular regarding the .. 
09/09Eyegate Pharmaceuticals $EYEG and Galena Biopharma $GALE Head-To-Head Compari.. 
09/09Galena Biopharma Settles Opioid Kickback Allegations:  
09/08BRIEF-U.S. DOJ says Galena Biopharma to pay over $7.55 mln to resolve alleged.. 
More tweets
Qtime:12
News from SeekingAlpha
2016 Galena Biopharma's (GALE) CEO Mark Schwartz on Q3 2016 Results - Earnings Cal..
2016 Galena Biopharma beats by $0.02
2016 Notable earnings after Wednesday?s close
2016 RXI PHARMACEUTICALS : Moving On Promising Scar Treatment
2016 Best And Worst Performing Stocks Of 2016
Technical analysis trends GALENA BIOPHARMA INC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
 
Mean consensus HOLD
Number of Analysts 2
Average target price -
Spread / Average Target -100%
EPS Revisions
Managers
NameTitle
Stephen F. Ghiglieri CEO, CFO & Principal Accounting Officer
Sanford J. Hillsberg Chairman
Bijan Nejadnik Chief Medical Officer & Executive Vice President
Stephen S. Galliker Independent Director
Rudolph Nisi Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
GALENA BIOPHARMA INC14
JOHNSON & JOHNSON14.04%352 060
NOVARTIS12.62%226 442
ROCHE HOLDING LTD.6.62%222 309
PFIZER10.75%211 467
MERCK AND COMPANY10.72%177 769